HEADER TRANSFERASE 31-MAR-14 4PZV
TITLE CRYSTAL STRUCTURE OF FRANCISELLA TULARENSIS HPPK-DHPS IN COMPLEX WITH
TITLE 2 BISUBSTRATE ANALOG HPPK INHIBITOR J1D
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: 2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE
COMPND 3 PYROPHOSPHOKINASE/DIHYDROPTEROATE SYNTHASE;
COMPND 4 CHAIN: A;
COMPND 5 EC: 2.5.1.15, 2.7.6.3;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: FRANCISELLA TULARENSIS SUBSP. TULARENSIS;
SOURCE 3 ORGANISM_TAXID: 177416;
SOURCE 4 STRAIN: SCHU S4 / SCHU 4;
SOURCE 5 GENE: FOIK, FOLK, FTT_0942C;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS(DE3)-RIL;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDN2163
KEYWDS FERREDOXIN-LIKE FOLD; TIM BARREL FOLD, TRANSFERASE, ATP BINDING,
KEYWDS 2 PHOSPHORYLATION
EXPDTA X-RAY DIFFRACTION
AUTHOR G.X.SHAW,G.SHI,X.JI
REVDAT 4 20-SEP-23 4PZV 1 REMARK
REVDAT 3 30-AUG-23 4PZV 1 AUTHOR JRNL REMARK
REVDAT 2 01-OCT-14 4PZV 1 JRNL
REVDAT 1 16-JUL-14 4PZV 0
JRNL AUTH G.X.SHAW,Y.LI,G.SHI,Y.WU,S.CHERRY,D.NEEDLE,D.ZHANG,
JRNL AUTH 2 J.E.TROPEA,D.S.WAUGH,H.YAN,X.JI
JRNL TITL STRUCTURAL ENZYMOLOGY AND INHIBITION OF THE BI-FUNCTIONAL
JRNL TITL 2 FOLATE PATHWAY ENZYME HPPK-DHPS FROM THE BIOWARFARE AGENT
JRNL TITL 3 FRANCISELLA TULARENSIS.
JRNL REF FEBS J. V. 281 4123 2014
JRNL REFN ISSN 1742-464X
JRNL PMID 24975935
JRNL DOI 10.1111/FEBS.12896
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH G.SHI,J.BLASZCZYK,X.JI,H.YAN
REMARK 1 TITL BISUBSTRATE ANALOGUE INHIBITORS OF
REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE:
REMARK 1 TITL 3 SYNTHESIS AND BIOCHEMICAL AND CRYSTALLOGRAPHIC STUDIES.
REMARK 1 REF J.MED.CHEM. V. 44 1364 2001
REMARK 1 REFN ISSN 0022-2623
REMARK 1 PMID 11311059
REMARK 1 REFERENCE 2
REMARK 1 AUTH G.SHI,G.SHAW,Y.H.LIANG,P.SUBBURAMAN,Y.LI,Y.WU,H.YAN,X.JI
REMARK 1 TITL BISUBSTRATE ANALOGUE INHIBITORS OF
REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE: NEW
REMARK 1 TITL 3 DESIGN WITH IMPROVED PROPERTIES.
REMARK 1 REF BIOORG.MED.CHEM. V. 20 47 2012
REMARK 1 REFN ISSN 0968-0896
REMARK 1 PMID 22169600
REMARK 1 DOI 10.1016/J.BMC.2011.11.032
REMARK 1 REFERENCE 3
REMARK 1 AUTH G.SHI,G.SHAW,Y.LI,Y.WU,H.YAN,X.JI
REMARK 1 TITL BISUBSTRATE ANALOG INHIBITORS OF
REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE: NEW
REMARK 1 TITL 3 LEAD EXHIBITS A DISTINCT BINDING MODE.
REMARK 1 REF BIOORG.MED.CHEM. V. 20 4303 2012
REMARK 1 REFN ISSN 0968-0896
REMARK 1 PMID 22727779
REMARK 1 DOI 10.1016/J.BMC.2012.05.060
REMARK 2
REMARK 2 RESOLUTION. 1.70 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.8.4_1496
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.11
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.500
REMARK 3 COMPLETENESS FOR RANGE (%) : 89.7
REMARK 3 NUMBER OF REFLECTIONS : 43002
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.212
REMARK 3 R VALUE (WORKING SET) : 0.210
REMARK 3 FREE R VALUE : 0.259
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.280
REMARK 3 FREE R VALUE TEST SET COUNT : 979
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 28.1101 - 3.2582 0.99 6720 166 0.1644 0.2092
REMARK 3 2 3.2582 - 2.5867 0.96 6460 150 0.1808 0.2282
REMARK 3 3 2.5867 - 2.2599 0.94 6281 160 0.1913 0.2789
REMARK 3 4 2.2599 - 2.0533 0.93 6217 143 0.2230 0.2748
REMARK 3 5 2.0533 - 1.9062 0.89 5972 127 0.2667 0.3121
REMARK 3 6 1.9062 - 1.7938 0.84 5581 130 0.3284 0.3717
REMARK 3 7 1.7938 - 1.7040 0.72 4792 103 0.3597 0.3843
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.10
REMARK 3 SHRINKAGE RADIUS : 1.10
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.570
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 13.30
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.42
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.009 3665
REMARK 3 ANGLE : 1.075 4957
REMARK 3 CHIRALITY : 0.062 560
REMARK 3 PLANARITY : 0.005 636
REMARK 3 DIHEDRAL : 12.519 1444
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4PZV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-APR-14.
REMARK 100 THE DEPOSITION ID IS D_1000085427.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 18-MAY-12
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SSRL
REMARK 200 BEAMLINE : BL9-2
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000
REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR
REMARK 200 OPTICS : MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43013
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700
REMARK 200 RESOLUTION RANGE LOW (A) : 30.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0
REMARK 200 DATA REDUNDANCY : 3.500
REMARK 200 R MERGE (I) : 0.08700
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.7000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76
REMARK 200 COMPLETENESS FOR SHELL (%) : 72.1
REMARK 200 DATA REDUNDANCY IN SHELL : 1.90
REMARK 200 R MERGE FOR SHELL (I) : 0.40500
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.900
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHENIX
REMARK 200 STARTING MODEL: PDB ENTRIES 3UDE AND 1TWS
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 46.62
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG MONOMETHYL ETHER 2000, NACL, PH
REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 292K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.21700
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ASN A 180
REMARK 465 GLN A 181
REMARK 465 SER A 182
REMARK 465 PHE A 183
REMARK 465 LYS A 216
REMARK 465 PRO A 217
REMARK 465 ASP A 218
REMARK 465 ALA A 219
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASN A 10 16.72 -140.59
REMARK 500 TRP A 94 -10.06 72.90
REMARK 500 GLU A 107 -123.30 50.87
REMARK 500 PHE A 188 31.65 -146.06
REMARK 500 ASP A 190 34.70 -151.77
REMARK 500 CYS A 280 41.46 -80.01
REMARK 500 CYS A 280 42.80 -80.01
REMARK 500 ASP A 391 33.43 -87.70
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE J1D A 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 502
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 503
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 504
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 505
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 506
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 507
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 508
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4F7V RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF ESCHERICHIA COLI HPPK IN COMPLEX WITH
REMARK 900 BISUBSTRATE ANALOG INHIBITOR J1D
DBREF 4PZV A 1 421 UNP Q5NGA7 Q5NGA7_FRATT 1 421
SEQRES 1 A 421 MET GLN TYR ILE ILE GLY ILE GLY THR ASN ILE GLY PHE
SEQRES 2 A 421 THR ILE GLU ASN ILE HIS LEU ALA ILE THR ALA LEU GLU
SEQRES 3 A 421 SER GLN GLN ASN ILE ARG ILE ILE ARG LYS ALA SER LEU
SEQRES 4 A 421 TYR SER SER LYS ALA VAL LEU LYS GLU ASP ALA PRO LYS
SEQRES 5 A 421 GLU TRP ASP ILE ARG PHE LEU ASN THR ALA VAL LYS ILE
SEQRES 6 A 421 SER SER SER LEU LYS PRO ASP GLU LEU LEU VAL LEU LEU
SEQRES 7 A 421 LYS ASP ILE GLU LEU LYS ILE GLY ARG ASP LEU ASN ALA
SEQRES 8 A 421 PRO ALA TRP SER PRO ARG VAL ILE ASP LEU ASP ILE LEU
SEQRES 9 A 421 ALA ALA GLU ASP LEU ILE LEU GLU THR ASP LYS LEU THR
SEQRES 10 A 421 ILE PRO HIS LYS GLU LEU ILE ASN ARG SER PHE ALA LEU
SEQRES 11 A 421 ALA PRO LEU LEU GLU LEU SER LYS GLY TRP HIS HIS PRO
SEQRES 12 A 421 LYS TYR VAL GLU TRP ASP LEU ASN ILE ARG LEU LYS GLU
SEQRES 13 A 421 LEU GLY GLU ILE VAL LYS LEU LYS GLN THR LEU ALA ASN
SEQRES 14 A 421 THR ILE ARG MET GLY ILE VAL ASN LEU SER ASN GLN SER
SEQRES 15 A 421 PHE SER ASP GLY ASN PHE ASP ASP ASN GLN ARG LYS LEU
SEQRES 16 A 421 ASN LEU ASP GLU LEU ILE GLN SER GLY ALA GLU ILE ILE
SEQRES 17 A 421 ASP ILE GLY ALA GLU SER THR LYS PRO ASP ALA LYS PRO
SEQRES 18 A 421 ILE SER ILE GLU GLU GLU PHE ASN LYS LEU ASP GLU PHE
SEQRES 19 A 421 LEU GLU TYR PHE LYS SER GLN LEU ALA ASN LEU ILE TYR
SEQRES 20 A 421 LYS PRO LEU VAL SER ILE ASP THR ARG LYS LEU GLU VAL
SEQRES 21 A 421 MET GLN LYS ILE LEU ALA LYS HIS HIS ASP ILE ILE TRP
SEQRES 22 A 421 MET ILE ASN ASP VAL GLU CYS ASN ASN ILE GLU GLN LYS
SEQRES 23 A 421 ALA GLN LEU ILE ALA LYS TYR ASN LYS LYS TYR VAL ILE
SEQRES 24 A 421 ILE HIS ASN LEU GLY ILE THR ASP ARG ASN GLN TYR LEU
SEQRES 25 A 421 ASP LYS GLU ASN ALA ILE ASP ASN VAL CYS ASP TYR ILE
SEQRES 26 A 421 GLU GLN LYS LYS GLN ILE LEU LEU LYS HIS GLY ILE ALA
SEQRES 27 A 421 GLN GLN ASN ILE TYR PHE ASP ILE GLY PHE GLY PHE GLY
SEQRES 28 A 421 LYS LYS SER ASP THR ALA ARG TYR LEU LEU GLU ASN ILE
SEQRES 29 A 421 ILE GLU ILE LYS ARG ARG LEU GLU LEU LYS ALA LEU VAL
SEQRES 30 A 421 GLY HIS SER ARG LYS PRO SER VAL LEU GLY LEU ALA LYS
SEQRES 31 A 421 ASP SER ASN LEU ALA THR LEU ASP ARG ALA THR ARG GLU
SEQRES 32 A 421 LEU SER ARG LYS LEU GLU LYS LEU ASP ILE ASP ILE ILE
SEQRES 33 A 421 ARG VAL HIS LYS ILE
HET J1D A 501 44
HET EDO A 502 4
HET EDO A 503 8
HET EDO A 504 4
HET EDO A 505 4
HET EDO A 506 8
HET EDO A 507 4
HET EDO A 508 4
HETNAM J1D 5'-{[2-({N-[(2-AMINO-7,7-DIMETHYL-4-OXO-3,4,7,8-
HETNAM 2 J1D TETRAHYDROPTERIDIN-6-YL)CARBONYL]GLYCYL}AMINO)
HETNAM 3 J1D ETHYL]SULFONYL}-5'-DEOXYADENOSINE
HETNAM EDO 1,2-ETHANEDIOL
HETSYN EDO ETHYLENE GLYCOL
FORMUL 2 J1D C23 H30 N12 O8 S
FORMUL 3 EDO 7(C2 H6 O2)
FORMUL 10 HOH *430(H2 O)
HELIX 1 1 PHE A 13 SER A 27 1 15
HELIX 2 2 PRO A 51 ASP A 55 5 5
HELIX 3 3 LYS A 70 GLY A 86 1 17
HELIX 4 4 GLU A 122 ASN A 125 5 4
HELIX 5 5 ARG A 126 SER A 137 1 12
HELIX 6 6 ASP A 149 GLY A 158 1 10
HELIX 7 7 ASN A 191 GLY A 204 1 14
HELIX 8 8 SER A 223 LEU A 242 1 20
HELIX 9 9 ALA A 243 LEU A 245 5 3
HELIX 10 10 LYS A 257 HIS A 269 1 13
HELIX 11 11 ASP A 270 ILE A 272 5 3
HELIX 12 12 ASN A 282 ASN A 294 1 13
HELIX 13 13 ASP A 307 TYR A 311 5 5
HELIX 14 14 ASN A 316 LYS A 334 1 19
HELIX 15 15 ALA A 338 GLN A 340 5 3
HELIX 16 16 LYS A 353 ASN A 363 1 11
HELIX 17 17 ASN A 363 GLU A 372 1 10
HELIX 18 18 LYS A 382 GLY A 387 1 6
HELIX 19 19 ASN A 393 ASP A 412 1 20
SHEET 1 A 4 ILE A 31 LYS A 36 0
SHEET 2 A 4 PHE A 58 SER A 67 -1 O SER A 66 N ARG A 32
SHEET 3 A 4 GLN A 2 THR A 9 -1 N ILE A 7 O THR A 61
SHEET 4 A 4 ASP A 100 ALA A 105 -1 O ALA A 105 N ILE A 4
SHEET 1 B 4 ILE A 31 LYS A 36 0
SHEET 2 B 4 PHE A 58 SER A 67 -1 O SER A 66 N ARG A 32
SHEET 3 B 4 TYR A 40 SER A 42 -1 N SER A 42 O PHE A 58
SHEET 4 B 4 VAL A 161 LYS A 162 -1 O VAL A 161 N SER A 41
SHEET 1 C 2 LEU A 111 GLU A 112 0
SHEET 2 C 2 THR A 117 ILE A 118 -1 O ILE A 118 N LEU A 111
SHEET 1 D 9 ILE A 171 ASN A 177 0
SHEET 2 D 9 ILE A 207 GLY A 211 1 O ASP A 209 N GLY A 174
SHEET 3 D 9 LEU A 250 THR A 255 1 O ASP A 254 N ILE A 210
SHEET 4 D 9 MET A 274 ASP A 277 1 O ASN A 276 N ILE A 253
SHEET 5 D 9 LYS A 296 ILE A 300 1 O LYS A 296 N ILE A 275
SHEET 6 D 9 ILE A 342 ASP A 345 1 O TYR A 343 N ILE A 299
SHEET 7 D 9 LYS A 374 VAL A 377 1 O LEU A 376 N PHE A 344
SHEET 8 D 9 ILE A 415 VAL A 418 1 O ILE A 415 N VAL A 377
SHEET 9 D 9 ILE A 171 ASN A 177 1 N MET A 173 O ILE A 416
CISPEP 1 ILE A 118 PRO A 119 0 -2.94
SITE 1 AC1 22 SER A 42 LYS A 43 VAL A 45 PHE A 58
SITE 2 AC1 22 ASN A 60 LEU A 75 LYS A 79 ARG A 87
SITE 3 AC1 22 TRP A 94 ARG A 97 ASP A 100 ASP A 102
SITE 4 AC1 22 ILE A 103 LYS A 115 LEU A 116 THR A 117
SITE 5 AC1 22 PHE A 128 HOH A 693 HOH A 707 HOH A 767
SITE 6 AC1 22 HOH A 825 HOH A 861
SITE 1 AC2 6 TYR A 145 ASN A 316 ASN A 320 HOH A 659
SITE 2 AC2 6 HOH A 709 HOH A 718
SITE 1 AC3 6 ASN A 177 THR A 215 ARG A 417 HIS A 419
SITE 2 AC3 6 HOH A 763 HOH A 774
SITE 1 AC4 6 GLN A 2 ILE A 4 LYS A 64 GLU A 107
SITE 2 AC4 6 SER A 137 TRP A 140
SITE 1 AC5 2 LEU A 77 LYS A 84
SITE 1 AC6 4 VAL A 161 LYS A 162 LYS A 164 GLN A 202
SITE 1 AC7 3 ASP A 323 GLU A 326 ARG A 370
SITE 1 AC8 7 LYS A 138 TRP A 140 HIS A 141 TRP A 148
SITE 2 AC8 7 ASP A 149 LEU A 150 ASN A 151
CRYST1 42.945 74.434 69.758 90.00 93.20 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.023286 0.000000 0.001302 0.00000
SCALE2 0.000000 0.013435 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014358 0.00000